Memory for new information as a cognitive marker of liability to Alzheimer's disease in a high risk group: A research note

International Journal of Geriatric Psychiatry

Volumn 18, Issue 2, 2003, Pages 155-160

  Rice, Frances ^a   Abraham, Richard ^a   Rudrasingham, Varuni ^a   Owen, Michael J ^a   Williams, Julie ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's; apoE; Cognition; Doors and People Test; First degree relative; Genetic; High risk; Memory; Pre clinical

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMENTIA; ELDERLY CARE; FEMALE; GERIATRIC CARE; HIGH RISK PATIENT; HUMAN; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; NEUROPSYCHOLOGY; PREDICTION; SIBLING; STATISTICAL ANALYSIS; TASK PERFORMANCE; VERBAL COMMUNICATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; MEMORY; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS; VERBAL BEHAVIOR;

EID: 0037326734     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.808     Document Type: Article

References (38)

1. Baddeley A, Emslie H, Nimmo-Smith I. 1996. The Doors and People Test. Thames Valley Test Company.
2. Bowen J, Teri L, Kukull W, et al. 1997. Progression to dementia in patients with isolated memory loss. Lancet 349: 763-765.
3. Daw EW, Payami H, Nemens EJ, et al. 2000. The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66: 196-204.
4. Fabrigoule C, Rouch I, Taberly A, et al. 1998. Cognitive processes in preclinical phase of dementia. Brain 121: 135-141.
5. Farrer LA, Cupples LA, Haines JL, et al. 1997. Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease - A meta-analysis. JAMA 278: 1349-1356.
6. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-Mental State.' A practical method for grading the state of patients for the clinician. J Psychiatry Res 12: 189-198.
7. Fox NC, Warrington EK, Rossor MN. 1999. Serial magnetic resonance imaging in cerebral atrophy in preclinical Alzheimer's disease. Lancet 353: 2125-2125.
8. Fox NC, Warrington EK, Seiffer AL, et al. 1998. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease: A longitudinal prospective study. Brain 121: 1631-1639.
9. Fuld PA, Masur DM, Blau AD, et al. 1990. Object-memory evaluation for prospective detection of dementia in normal functioning elderly: Predictive and normative data. J Clin Expl Neuropsych 12: 520-528.
10. Greene JDW, Baddeley AD, Hodges JR. 1996. Analysis of the episodic memory deficit in early Alzheimer's disease: Evidence from the doors and people test. Neuropsychologia 34: 537-551.
11. Helkala EL, Koivisto K, Hanninen T, et al. 1996. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3 year population based follow-up study. Neurosci Lett 204: 177-180.
12. Holmes C, Cairns N, Lantos P, Mann A. 1999. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. B J Psychiatry 174: 45-50.
13. Katzman R, Aronson M, Fuld P, et al. 1989. Development of dementing illness in an 80 year old volunteer cohort. Ann Neurol 25: 317-324.
14. Kim KW, Youn JC, Jhoo JH, et al. 2002. Apolipoprotein E ε4 is not associated with the cognitive impairment in community-dwelling normal elderly individuals. Int J Geriatr Psychiatry 17: 635-640.
15. La Rue A, Jarvik LF. 1980. Reflections in biological changes in the psychological performance of the aged. Age 3: 29-32.
16. Liddell MB, Lovestone S, Owen MJ. 2000. Genetic risk of Alzheimer's disease: Advising relatives. B J Psychiatry 178: 7-11.
17. Linn RT, Wolf PA, Bachman DL, et al. 1995. The 'preclinical phase' of probable Alzheimer's disease. A 13 year prospective study of the Framingham cohort. Arch Neurol 52: 485-490.
18. Masur DM, Sliwinski M, Lipton RB, et al. 1994. Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 44: 1427-1432.
19. Mayeux R, Small S, Tang M, et al. 2001. Memory performance in healthy elderly without Alzheimer's disease: Effects of time and apolipoprotein-E. Neurobiol Aging 22: 638-689.
20. McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939.
21. Meyers A, Holmans P, Marshall H, et al. 2000. Susceptibility locus for Alzheimer's disease on chromosome 10. Science 290: 2304-2305.
22. Nelson HE, Willison JR. 1991. National Adult Reading Test (NART). NFER Nelson: Windsor.
23. Peteresen RC, Smith G, Ivnik RJ, et al. 1995. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 273: 1274-1278.
24. Price JL, Morris JC. 1999. Tangles and plaques in nondemented aging and preclinical AD. Ann Neurol 45: 358-368.
25. Raiha L, Kaprio J, Kosekenvuo M, et al. 1997. Alzheimer's disease in twins. Biomed Psychopharmacol 51: 101-104.
26. Small BJ, Herlitz A, Fratiglioni L, et al. 1997. Cognitive predictors of incident Alzheimer's disease: A prospective longitudinal study. Neuropsych 11: 413-420.
27. Small GW, Ercoli LM, Silverman DHS, et al. 2000. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA 97: 6037-6042.
28. Spinhoven PH, Ormel J, Sloekers PPA, et al. 1997. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27: 363-370.
29. Spreen O, Strauss EA. 1998. Compendium of Neuropsychological Tests, 2nd edn. Oxford University Press: Oxford.
30. Statistical Package for the Social Sciences Windows 1999. Norusis/SPSS Inc.
31. Swainson R, Hodges JR, Galton CJ, et al. 2000. Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks. Dement Geriatr Cogn Disord 12: 265-280.
32. Tierney MC, Szalai JP, Snow WG, et al. 1996a. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology 46: 149-154.
33. Tierney MC, Szalai JP, Snow WG, et al. 1996b. Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology 46: 661-665.
34. Van Duijn CM, Clayton D, Chandra V, et al. 1991. Familial aggregation of Alzheimer's disease and related disorders: A collaborative reanalysis of case-control studies. Int J Epidemiol 20: S13-S20.
35. Wenham PR, Price WH, Blundell G. 1991. Apolipoprotein E genotyping by one stage PCR. Lancet 337: 1158-1159.
36. Williams J. 2002. Dementia and genetics. In Behavioral Genetics in the Postgenomic Era, Plomin R, DeFries JC, Craig IW, McGuffin P (eds). American Psychological Association: Washington, DC.
37. Winnock M, Letenneur L, Jacqmin-Gadda J, et al. 2002. Longitudinal analysis of the effect of apolipoprotein E ε4 and education on cognitive performance in elderly subjects: The PAQUID study. J Neurol Neurosurg Psychiatry 72: 794-797.
38. Zigmond AS, Snaith RP. 1983. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67: 361-370.